Hepatic Ascites
📧 Sign up to get email alerts when something new happens for Hepatic Ascites.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Recombinant Human Serum Albumin in Healthy Subjects [Phase 1]
Phase 1 clinical trial evaluating recombinant human serum albumin in healthy subjects, sponsored by Protgen Ltd. Hepatic Ascites is listed a…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects [Phase 1]
A Phase 1 clinical trial evaluating recombinant human serum albumin in patients with liver cirrhosis and ascites has completed.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics [Phase 1]
Phase 1 clinical trial update for PHIN-214 assessing single and multiple dose escalation in adults with liver cirrhosis (Child-Pugh A and B)…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: QOL and Sarcopenia in Patients With Ascites
A clinical trial is ongoing to assess quality of life and sarcopenia in patients with hepatic and malignant ascites; recruitment is currentl…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With Ascites [Phase 3]
This document provides an update on a Phase 3 trial evaluating recombinant human albumin injections to treat hypoalbuminemia in cirrhotic pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Achieving Portal Access With Scorpion Post-Approval Study 2
The Scorpion post-approval study 2 has completed, evaluating portal access with Argon Medical Devices' Scorpion system in patients with port…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Phase II/III of Recombinant Human Albumin Injection [Phase 2]
A Phase II/III trial evaluating recombinant human albumin injection for hepatic ascites has completed its Phase 2 portion.
-
FDA approval · 2023-05-10FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites [Phase 2]
Phase 2 trial evaluating adding hypertonic saline solutions and/or etilefrine to standard diuretic therapy for hepatic ascites has completed…